Clinical Trial Update: Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update outlines the ongoing evaluation of Stempeucel for critical limb ischemia due to peripheral arterial disease, with recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Arterial Disease

Drugs mentioned

• Stempeucel (mesenchymal stromal cells)

Snippet

Sponsor: Cell Biopeutics Resources Sdn Bhd | Conditions: Critical Limb Ischemia, Peripheral Arterial Disease | Phase 4 | Status: RECRUITING